Benefits
Blood Pressure Measures
Results are mixed. A 2025 pooled analysis of 10 randomized trials found no overall effect on blood pressure, with lower systolic pressure only in trials giving over 50 mg of anthocyanins a day, and rated certainty very low. A 2019 pooled analysis of 7 trials found no effect on systolic pressure and a small rise in diastolic pressure. In a 38-person crossover trial in mildly raised blood pressure, daytime diastolic pressure fell 1.6 mmHg.
Blood Lipid Support: Total and LDL Cholesterol
In a 12-week placebo-controlled trial in 49 former smokers, 500 mg a day of aronia extract lowered total cholesterol by 8% and LDL cholesterol by 11%. Pooled results are less consistent: a 2019 analysis found lower total and LDL cholesterol only in trials shorter than 10 weeks, and a 2025 analysis found no overall effect, with lower values only where cholesterol started below 200 mg/dL.
Antioxidant Enzyme Support
In a double-blind trial in 70 healthy middle-aged adults who ate little fruit and vegetables, 300 mg a day of aronia extract for 8 weeks raised glutathione and glutathione peroxidase activity after a treadmill test compared with placebo. A 2025 review of 18 randomized trials reported higher antioxidant enzyme activity in several studies, but a 12-week trial in former smokers found no change in oxidative stress markers.
Arterial Function Support
In a 12-week double-blind trial in 102 middle-aged adults with higher than ideal blood pressure, an aronia extract did not change blood pressure, the registered primary outcome, but improved arterial stiffness measures (pulse wave velocity and augmentation index) compared with placebo. Endothelial function (flow-mediated dilation) and blood lipids did not change. Several authors were employed or funded by the ingredient company Naturex.
Inflammation Marker Support
Results are mixed. A 2025 review of 18 randomized trials reported lower CRP, TNF-alpha and IL-6 in several studies, and in 38 adults with mildly raised blood pressure TNF-alpha fell over 8 weeks. But a 2019 pooled analysis of 7 trials found no significant effect on CRP, TNF or IL-1, and a 12-week trial in former smokers found no change in inflammation markers.
Mechanism of action
Anthocyanin Antioxidant Activity
Aronia is rich in anthocyanins, mainly cyanidin glycosides. In laboratory work these compounds neutralize free radicals and are proposed to switch on the cell's own antioxidant enzymes. In people, effects have only been measured as blood enzyme and marker changes, with mixed results across trials.
Endothelial Nitric Oxide Modulation
Laboratory work suggests aronia polyphenols support nitric oxide signalling in blood vessel walls. In the largest trial cited here, arterial stiffness improved but flow-mediated dilation, a measure of endothelial function, did not change, so this pathway is not confirmed in people.
Cholesterol Handling
In the former-smoker trial, the cholesterol drop came with lower LDL receptor protein in blood immune cells and was most closely linked to urinary levels of cyanidin-3-galactoside and its metabolite peonidin-3-galactoside. How aronia affects cholesterol is not established.
Inflammation Signalling and Gut Microbiome
Anthocyanins are proposed to dampen inflammatory signalling such as NF-kB in laboratory studies. In a 12-week trial, aronia extract increased gut microbiome gene richness and butyrate-producing bacteria, which the authors linked to its arterial effects; that link is an association, not a proven cause.
Blood Sugar Handling
Aronia extracts are proposed to slow starch-digesting enzymes in laboratory studies. In people, the 2025 pooled analysis found no overall effect on fasting blood sugar, and in adults aged 50 or younger fasting blood sugar rose in the subgroup analysis.
Clinical trials
Systematic review and meta-analysis of randomized controlled trials of chokeberry supplementation lasting at least 2 weeks in adults, searched through January 2025, with certainty rated by GRADE. (Frumuzachi et al. 2025, Nutrients)
10 randomized trials, 666 adults with or without cardiometabolic risk factors.
Chokeberry had no significant effect on body measures, blood sugar, blood lipids or blood pressure overall. Subgroups suggested lower total and LDL cholesterol when cholesterol started below 200 mg/dL, lower systolic pressure with more than 50 mg/day of anthocyanins, and higher fasting glucose in adults aged 50 or younger. Risk of bias was unclear or high in several trials and certainty was very low for every outcome.
Systematic review and meta-analysis of randomized controlled trials of aronia on lipids, blood pressure and inflammation markers, searched to December 2018. (Rahmani et al. 2019, Phytother Res)
7 randomized controlled trials.
HDL cholesterol rose by 1.48 mg/dL and, unexpectedly, diastolic blood pressure rose by 2.55 mmHg. There was no significant effect on systolic blood pressure, CRP, TNF or IL-1. Total and LDL cholesterol fell only in the subgroup of trials shorter than 10 weeks.
12-week randomized placebo-controlled trial of 500 mg/day aronia extract; the primary outcome was change in LDL cholesterol. (Xie et al. 2017, Nutr Res)
49 healthy adult former smokers (25 aronia, 24 placebo).
Compared with placebo, total cholesterol fell 8% and LDL cholesterol 11%. Blood pressure, inflammation markers and oxidative stress markers did not change.
12-week randomized double-blind placebo-controlled parallel trial of an encapsulated aronia (poly)phenol extract versus maltodextrin; the registered primary outcome was 24-hour ambulatory blood pressure, and several authors were employed or funded by the industry collaborator Naturex. (Le Sayec et al. 2022, Clin Nutr)
102 middle-aged men and women with prehypertension (51 per group).
Blood pressure, the registered primary outcome, did not change. Arterial stiffness measures (pulse wave velocity and augmentation index) improved compared with placebo, while endothelial function (flow-mediated dilation) and blood lipids did not change. Gut microbiome gene richness and butyrate-producing species increased.
8-week double-blind randomized controlled trial of 300 mg/day aronia berry extract, with a 30-minute treadmill test at the end used to create oxidative stress. (Chung et al. 2023, J Hum Nutr Diet)
70 healthy middle-aged adults with habitually low fruit and vegetable intake.
Compared with placebo, the extract group had higher reduced glutathione availability and glutathione peroxidase activity immediately and 30 minutes after exercise. These are blood markers of antioxidant defense, not health outcomes.